Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course.
Branton
Mary H
MH
Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland 20892-1268, USA.
Schiffmann
Raphael
R
Sabnis
Sharda G
SG
Murray
Gary J
GJ
Quirk
Jane M
JM
Altarescu
Gheona
G
Goldfarb
Lev
L
Brady
Roscoe O
RO
Balow
James E
JE
Austin Iii
Howard A
HA
Kopp
Jeffrey B
JB
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D000795:Fabry Disease / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology* / Q000601:surgery; D006801:Humans; D006977:Hypertension, Renal / Q000453:epidemiology / Q000209:etiology; D007223:Infant; D007231:Infant, Newborn; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology* / Q000601:surgery; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000209:etiology; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011507:Proteinuria / Q000453:epidemiology / Q000209:etiology; D014481:United States / Q000453:epidemiology; D000519:alpha-Galactosidase / Q000235:genetics* / Q000378:metabolism*
D000519:alpha-Galactosidase